JPRN-UMIN000006088招募中未知
Beta cell regeneration therapy for type 1 diabetes by GLP-1 receptor agonist and insulin - Beta cell regeneration therapy for type 1 diabetes by GLP-1 receptor agonist and insulin
Department of Metabolic Medicine, Graduate School of Medicine, Osaka University0 个研究点目标入组 24 人开始时间: 2011年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 24
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 59years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •-History or presence of heart failure -Presence of severe hepatic or/and renal dysfunction -History or presence of alcoholic or severe infectious disease -Pregnancy -Other inappropriate patients judged by doctor
研究者
相似试验
撤回
2 期
Beta Cell Rescue in New Onset Type 1 Diabetes With EfalizumabDiabetes Mellitus, Type 1NCT00737763Emory University
已完成
不适用
Cellular therapy of type 1 diabetes with T regulatory cellsDiabetes type 1Nutritional, Metabolic, EndocrineInsulin-dependent diabetes mellitusISRCTN06128462Medical University of Gdansk (Poland)20
终止
2 期
Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 DiabetesDiabetes Mellitus Type 1Autoimmune DiabetesNCT00837759National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)7
已完成
2 期
Baricitinib in New-onset Type 1 DiabetesType 1 DiabetesNCT04774224St Vincent's Institute of Medical Research91
No Longer Available
不适用
B-Lymphocyte Immunotherapy in Islet Transplantation for Initial Islet Graft FailureType 1 Diabetes MellitusNCT01049633National Institute of Allergy and Infectious Diseases (NIAID)